ValuentumAd

Official PayPal Seal
Fundamental data is updated weekly, as of the prior weekend. Please download the Full Report and Dividend Report for any changes.
Jun 20, 2013
Generic Pharmaceuticals: Patent Expiration and Low Global Utilization Rates Create Opportunities
Big Pharma is not dead, but neither are the generics. Let’s take a look at opportunities presented from patent expiry in the US and low generic utilization rates across the globe. We don’t think investors are expecting the “mountain” of opportunities in 2015.
Jun 16, 2013
Valuentum's June Edition of Its Best Ideas Newsletter
The June edition of our Best Ideas Newsletter is now available.
Jun 15, 2013
Why Valuentum's Email Transaction Alerts Are Worth Paying Attention To
We take a look at the value generated by our transaction alert emails. The findings are startling!
Jun 11, 2013
If Yields Go Up, Are BDCs Done For?
Let’s take a look at Main Street and the BDC sector. Shares have been weak in anticipation of higher interest rates.
Jun 9, 2013
Valuentum’s Comprehensive Outlook for Crude Oil and Natural Gas Prices
Let’s take a deep dive into the energy sector. The best dividend growth ideas, the most likely takeout candidates and more...
Jun 7, 2013
Realty Income’s Monthly Dividend Should Continue to Grow
We're strongly evaluating Realty Income's shares for addition to the portfolio of our Dividend Growth Newsletter after its recent slide.
Jun 5, 2013
House Defense Appropriators Ignore Sequestration
The House Appropriations Committee released its fiscal year 2014 Defense Appropriations bill. Let’s take a look.
Jun 4, 2013
Evaluating the Industry Structure of Managed Care Organizations
We take a look at the managed care organization (MCO) and health insurance/benefits industry. We're comfortable being on the sidelines.
Jun 4, 2013
ASCO Reveals That Big Pharma Is Alive
Some good news from Bristol-Myers Squibb, Merck, GlaxoSmithKline, and Amgen showed the promise of immunotherapies for cancer treatment.
Jun 3, 2013
Revisiting the Real Risks of Linn Energy
To some, Linn Energy is a high-yielding savior; to others, it’s a Ponzi scheme. Let’s take a look at the controversial name.


The High Yield Dividend Newsletter, Best Ideas Newsletter, Dividend Growth Newsletter, Nelson Exclusive publication, and any reports, articles and content found on this website are for information purposes only and should not be considered a solicitation to buy or sell any security. The sources of the data used on this website are believed by Valuentum to be reliable, but the data’s accuracy, completeness or interpretation cannot be guaranteed. Valuentum is not responsible for any errors or omissions or for results obtained from the use of its newsletters, reports, commentary, or publications and accepts no liability for how readers may choose to utilize the content. Valuentum is not a money manager, is not a registered investment advisor and does not offer brokerage or investment banking services. Valuentum, its employees, and affiliates may have long, short or derivative positions in the stock or stocks mentioned on this site.